Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co appoints Frank Clyburn as president, human health

Clyburn joined the company in 2008, most recently serving as chief commercial officer for human health

Merck & Co – known as MSD outside the US and Canada – has appointed Frank Clyburn (pictured above) as president, human health.

In a statement, Merck & Co announced that Clyburn will take on the role effective immediately, and will lead all human health marketing and commercial operations.

He will be responsible for the company’s human health profit and loss (P&L) globally, reporting to Merck’s current chief executive officer Kenneth Frazier.

In January 2019, Clyburn became chief commercial officer for human health at Merck & Co.

Prior to this, he was president of the company’s global oncology business.

Clyburn joined Merck & Co in 2008 and during his time with the company, he has had responsibility for various global pharmaceutical franchises.

“I have tremendous respect for Frank’s strategic and operational excellence, and believe he is the perfect person to lead our ongoing success in human health,” said Robert Davis, executive vice president, global services and chief financial officer of Merck & Co.

“Frank’s leadership in rapidly expanding our oncology footprint and accelerating the growth of that business is unparalleled in our industry, exceeded only by his relentless dedication to helping patients. I look forward to continuing to work with him as we advance Merck’s mission to save and improve lives,” he added.

Article by
Lucy Parsons

19th March 2021

From: Research

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Market Shaping for Better Healthcare Decisions
82% of healthcare business professionals agreed that it is important to get market shaping right to achieve future brand success....
launch engagement
Launch engagement
How the pandemic is forcing a fresh focus on the human touch and fresh thinking about engagement...
Everything you need to know about patient groups and clinical trials
Patient advocacy groups (PAGs) and pharma/biopharma/biotech and MedTech industries are all working towards the same goal: to improve health outcomes. And as PAGs are key stakeholders in the clinical trial...